Thermo Fisher eyes Qiagen?
15/11/19 -"According to market rumours, US MedTech giant, Thermo Fisher, has mulled over a bid on Qiagen. While the transaction value isn’t available yet, Qiagen could command a c.25-40% premium to the ..."
Pages
62
Language
English
Published on
15/11/19
You may also be interested by these reports :
02/05/24
GN’s Q1 profitability beat the street’s expectations, despite sales being largely in line. The mid-single digit growth was led by Hearing, while ...
01/05/24
Drägerwerk reported Q1 24 numbers which were bang in-line with the prelims. Sales were down with the expected segmental trends. However, with a ...
30/04/24
The drop in our DCF valuation is largely a reflection of the double digit earnings cut for the next two forecast years, as we re-phase the delivery ...
30/04/24
Qiagen started 2024 on a decent note with the operating performance in line with the street’s expectations but above the management’s guidance. As ...